90% Healthy
Jeffrey Turk has been inside the stem cell industry long enough to know where the bodies are buried — figuratively speaking. As a disabled veteran, NBC Operations Specialist, and founder of Mount Hydra, Jeff came into this space because stem cells were the only thing that helped him. What he found was an industry riddled with counterfeit products, dead cells dressed up in premium packaging, and a regulatory gap wide enough to drive a clinic through. This episode is a buyer's guide disguised as a conversation. Jeff breaks down the three tests every biologic product should be able to show you before it goes anywhere near your body, explains why "1 trillion exosomes" is almost always a warning sign, and reveals the graft-versus-host disease risk buried inside cord blood treatments that practitioners are largely not disclosing. He also shares what he believes the next five years look like: customized exosome therapy by biomarker, longevity escape velocity, and off-the-shelf treatments for the cancers that currently carry the worst prognoses. If you or someone you know is considering stem cell or exosome therapy — or you're already a patient wondering if you got what you paid for — this is the episode to send them. The checklist Jeff recommends every patient ask for: 1. Endotoxin test results 2. Mycoplasma test results 3. Two-week sterility test results 4. Post-thaw viability (gold standard: 80%+) 5. Lot number and population doublings (cell age) 6. Cryopreservative confirmation for any Wharton's jelly product 7. CD63/CD81 marker confirmation for exosomes Jeff is currently working with AASCM to build a neutral, independent watchdog association for the stem cell industry — and he's offering to help patients and doctors who have questions. Connect with Jeffrey Turk:🌐 mounthydra.com Connect with the hosts of the 90% Healthy:🌐 Klaudia - longevityjournalist.com🌐 Don- trainrecoverwin.com
62 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de 90% Healthy!